| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 58.85B | 53.66B | 54.04B | 55.55B | 63.49B |
| Gross Profit | 15.60B | 30.28B | 32.40B | 34.27B | 44.93B |
| EBITDA | 22.31B | 23.16B | 21.08B | 25.54B | 36.13B |
| Net Income | 10.18B | 11.55B | 10.06B | 12.39B | 21.11B |
Balance Sheet | |||||
| Total Assets | 128.15B | 102.79B | 103.55B | 96.74B | 102.90B |
| Cash, Cash Equivalents and Short-Term Investments | 9.45B | 7.20B | 9.78B | 8.94B | 15.35B |
| Total Debt | 24.59B | 13.86B | 14.35B | 12.27B | 13.53B |
| Total Liabilities | 61.10B | 44.82B | 47.21B | 44.47B | 46.31B |
| Stockholders Equity | 62.23B | 55.25B | 54.59B | 50.17B | 51.43B |
Cash Flow | |||||
| Free Cash Flow | 4.91B | 5.98B | 8.07B | 9.38B | 17.96B |
| Operating Cash Flow | 17.51B | 15.60B | 15.16B | 16.13B | 25.34B |
| Investing Cash Flow | -18.08B | -9.59B | -6.96B | -6.71B | -7.16B |
| Financing Cash Flow | 864.77M | -7.09B | -5.28B | -15.47B | -15.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £116.00B | 6.00 | 16.59% | 4.75% | -3.50% | -7.04% | |
65 Neutral | £469.73M | 11.82 | 3.23% | ― | -32.18% | -58.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £64.74B | 176.08 | 0.96% | 1.89% | -1.06% | -285.88% | |
50 Neutral | £171.56M | -0.89 | -4.54% | 7.30% | 6.65% | -159.09% | |
48 Neutral | £33.38B | -11.13 | -20.10% | 0.80% | -27.65% | -160.77% |